Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Saredutant> ?p ?o. }
Showing items 1 to 69 of
69
with 100 items per page.
- Saredutant abstract "Saredutant (SR-48,968) is a drug that acts as a NK2 receptor antagonist. It was under development by Sanofi-Aventis as a novel antidepressant and anxiolytic and made it to phase III clinical trials. However, in May 2009, Sanofi-Aventis published its quarterly results and announced the cessation of 14 research/development projects, among which was saredutant for the treatment of major depressive disorder.".
- Saredutant atcPrefix "none".
- Saredutant casNumber "142001-63-6".
- Saredutant iupacName "N-[(2S)-4-(4-acetamido-4-phenylpiperidin-1-yl)- 2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide".
- Saredutant pubchem "104974".
- Saredutant thumbnail Saredutant.svg?width=300.
- Saredutant wikiPageID "7803166".
- Saredutant wikiPageRevisionID "585000521".
- Saredutant atcPrefix "none".
- Saredutant c "31".
- Saredutant casNumber "142001".
- Saredutant chembl "308148".
- Saredutant chemspiderid "94726".
- Saredutant cl "2".
- Saredutant h "35".
- Saredutant hasPhotoCollection Saredutant.
- Saredutant inchi "1".
- Saredutant inchikey "PGKXDIMONUAMFR-AREMUKBSBA".
- Saredutant iupacName "N-[-4-- 2-butyl]-N-methylbenzamide".
- Saredutant iupharLigand "2111".
- Saredutant molecularWeight "552.5345".
- Saredutant n "3".
- Saredutant o "2".
- Saredutant pubchem "104974".
- Saredutant smiles "Clc1ccc[C@H]CNC".
- Saredutant stdinchi "1".
- Saredutant stdinchikey "PGKXDIMONUAMFR-AREMUKBSSA-N".
- Saredutant verifiedrevid "418109599".
- Saredutant width "250".
- Saredutant subject Category:Acetanilides.
- Saredutant subject Category:Antidepressants.
- Saredutant subject Category:Anxiolytics.
- Saredutant subject Category:Benzamides.
- Saredutant subject Category:NK2_receptor_antagonists.
- Saredutant subject Category:Organochlorides.
- Saredutant subject Category:Piperidines.
- Saredutant type Acetanilide102674912.
- Saredutant type Acetanilides.
- Saredutant type Agent114778436.
- Saredutant type Analgesic102707683.
- Saredutant type Antidepressant102718811.
- Saredutant type Antidepressants.
- Saredutant type Anxiolytics.
- Saredutant type CausalAgent100007347.
- Saredutant type Drug103247620.
- Saredutant type DrugOfAbuse103248958.
- Saredutant type Matter100020827.
- Saredutant type Medicine103740161.
- Saredutant type MinorTranquilizer103771443.
- Saredutant type PhysicalEntity100001930.
- Saredutant type PsychotropicAgent104017429.
- Saredutant type Sedative-hypnotic104166841.
- Saredutant type Sedative104166553.
- Saredutant type Substance100020090.
- Saredutant type Tranquilizer104470232.
- Saredutant type Drug.
- Saredutant type DrugProduct.
- Saredutant type FunctionalSubstance.
- Saredutant comment "Saredutant (SR-48,968) is a drug that acts as a NK2 receptor antagonist. It was under development by Sanofi-Aventis as a novel antidepressant and anxiolytic and made it to phase III clinical trials. However, in May 2009, Sanofi-Aventis published its quarterly results and announced the cessation of 14 research/development projects, among which was saredutant for the treatment of major depressive disorder.".
- Saredutant label "Saredutant".
- Saredutant label "Sarédutant".
- Saredutant sameAs Sarédutant.
- Saredutant sameAs m.026dk9t.
- Saredutant sameAs Q3473757.
- Saredutant sameAs Q3473757.
- Saredutant sameAs Saredutant.
- Saredutant wasDerivedFrom Saredutant?oldid=585000521.
- Saredutant depiction Saredutant.svg.
- Saredutant isPrimaryTopicOf Saredutant.
